BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33015970)

  • 1. Stress-induced premature senescence activated by the SENEX gene mediates apoptosis resistance of diffuse large B-cell lymphoma via promoting immunosuppressive cells and cytokines.
    Wang J; Tao Q; Pan Y; Wanyan Z; Zhu F; Xu X; Wang H; Yi L; Zhou M; Zhai Z
    Immun Inflamm Dis; 2020 Dec; 8(4):672-683. PubMed ID: 33015970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-Induced Premature Senescence Promotes Proliferation by Activating the
    Wang J; Wang Z; Wang H; Wanyan Z; Pan Y; Zhu F; Tao Q; Zhai Z
    Turk J Haematol; 2019 Nov; 36(4):247-254. PubMed ID: 31327185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging of the cells: Insight into cellular senescence and detection Methods.
    Mohamad Kamal NS; Safuan S; Shamsuddin S; Foroozandeh P
    Eur J Cell Biol; 2020 Aug; 99(6):151108. PubMed ID: 32800277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma.
    Lv X; Feng L; Ge X; Lu K; Wang X
    J Exp Clin Cancer Res; 2016 Jul; 35(1):106. PubMed ID: 27364124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel cellular senescence gene, SENEX, is involved in peripheral regulatory T cells accumulation in aged urinary bladder cancer.
    Chen T; Wang H; Zhang Z; Li Q; Yan K; Tao Q; Ye Q; Xiong S; Wang Y; Zhai Z
    PLoS One; 2014; 9(2):e87774. PubMed ID: 24505313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDGFD induces ibrutinib resistance of diffuse large B‑cell lymphoma through activation of EGFR.
    Jin J; Wang L; Tao Z; Zhang J; Lv F; Cao J; Hu X
    Mol Med Rep; 2020 May; 21(5):2209-2219. PubMed ID: 32186759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial.
    Jiménez-Cortegana C; Palazón-Carrión N; Martin Garcia-Sancho A; Nogales-Fernandez E; Carnicero-González F; Ríos-Herranz E; de la Cruz-Vicente F; Rodríguez-García G; Fernández-Álvarez R; Rueda Dominguez A; Casanova-Espinosa M; Martínez-Banaclocha N; Gumà-Padrò J; Gómez-Codina J; Labrador J; Salar-Silvestre A; Rodriguez-Abreu D; Galvez-Carvajal L; Provencio M; Sánchez-Beato M; Guirado-Risueño M; Espejo-García P; Lejeune M; Álvaro T; Sánchez-Margalet V; de la Cruz-Merino L; ; ;
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34158317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress-induced premature senescence mediated by a novel gene, SENEX, results in an anti-inflammatory phenotype in endothelial cells.
    Coleman PR; Hahn CN; Grimshaw M; Lu Y; Li X; Brautigan PJ; Beck K; Stocker R; Vadas MA; Gamble JR
    Blood; 2010 Nov; 116(19):4016-24. PubMed ID: 20664062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ibrutinib inhibits mesenchymal stem cells-mediated drug resistance in diffuse large B-cell lymphoma].
    Wu L; Zhang YZ; Xia B; Li XW; Yuan T; Tian C; Zhao HF; Yu Y; Sotomayor E
    Zhonghua Xue Ye Xue Za Zhi; 2017 Dec; 38(12):1036-1042. PubMed ID: 29365396
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma.
    Yang JM; Jang JY; Jeon YK; Paik JH
    J Transl Med; 2018 Jun; 16(1):162. PubMed ID: 29890998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [5-FU-Injured Bone Marrow Stromal Cells Initiate Stress-induced Premature Senescence of Hematopoietic Cells].
    Xiong LR; Jing PW; Song XY; Wang YP; Wang L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1178-1186. PubMed ID: 28823289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma.
    He Y; Li J; Ding N; Wang X; Deng L; Xie Y; Ying Z; Liu W; Ping L; Zhang C; Song Y; Zhu J
    J Exp Clin Cancer Res; 2019 Feb; 38(1):86. PubMed ID: 30777096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of Treg cells and immune escape.
    Su X; Sun T; Li M; Xia Y; Li M; Wang D; Lu F; Ye J; Ji C
    J Transl Med; 2022 Aug; 20(1):378. PubMed ID: 35986288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human bone marrow-derived mesenchymal stem cells promote the growth and drug-resistance of diffuse large B-cell lymphoma by secreting IL-6 and elevating IL-17A levels.
    Zhong W; Zhu Z; Xu X; Zhang H; Xiong H; Li Q; Wei Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):73. PubMed ID: 30755239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular senescence in ageing, age-related disease and longevity.
    Sikora E; Bielak-Zmijewska A; Mosieniak G
    Curr Vasc Pharmacol; 2014; 12(5):698-706. PubMed ID: 24350932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?
    Mondello P; Steiner N; Willenbacher W; Ferrero S; Ghione P; Marabese A; Pitini V; Cuzzocrea S; Mian M
    Oncologist; 2016 Sep; 21(9):1107-12. PubMed ID: 27382029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma.
    Jiang L; Sun Y; Wang J; He Q; Chen X; Lan X; Chen J; Dou QP; Shi X; Liu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):453. PubMed ID: 31694672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIMD4 exhibits regulatory capability on the proliferation and apoptosis of diffuse large B-cell lymphoma cells via the Wnt/β-catenin pathway.
    Li Y; Zhang PY; Yang ZW; Ma F; Li FX
    J Gene Med; 2020 Aug; 22(8):e3186. PubMed ID: 32187802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.
    Zhong W; Xu X; Zhu Z; Du Q; Du H; Yang L; Ling Y; Xiong H; Li Q
    Oncotarget; 2017 Jul; 8(30):49757-49772. PubMed ID: 28537908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K/AKT inhibition reverses R-CHOP resistance by destabilizing SOX2 in diffuse large B cell lymphoma.
    Chen J; Ge X; Zhang W; Ding P; Du Y; Wang Q; Li L; Fang L; Sun Y; Zhang P; Zhou Y; Zhang L; Lv X; Li L; Zhang X; Zhang Q; Xue K; Gu H; Lei Q; Wong J; Hu W
    Theranostics; 2020; 10(7):3151-3163. PubMed ID: 32194860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.